Időskori makuladegeneráció: vizsgálatok itt: Franciaország

In Franciaország 27 Also abroad 218

27 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

2. fázisTaking people
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
Where
Bordeaux, Lyon Cedex 04, Marseille, Paris, Saint-Cyr-sur-Loire
Életkor
55 év to 64 év
People
110 worldwide
Run by
Galimedix Therapeutics Inc
See details and how to joinNCT06659549 · EU 2024-519128-26-00
2. fázisTaking people
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Where
Creteil Cedex, Dijon, Lyon Cedex 04, Paris, Saint-Cyr-Sur-Loire
Életkor
50 év and over
People
272 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07441642 · EU 2025-523704-77-00
3. fázisTaking people
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Where
Lyon, Montauban, Nantes, Paris, Poitiers, Strasbourg Cedex
Életkor
50 év and over
People
250 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06847542 · EU 2024-516924-32-00
3. fázisTaking people
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Where
Créteil, Dijon, Écully, Lille, Lyon Cedex 04, Marseille, Nantes, Nice, Paris Cedex 10, Poitiers, Rouen, Toulouse
Életkor
50 év to 85 év
People
975 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06541704 · EU 2023-509547-27-00
3. fázisTaking people
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Where
Bordeaux, Créteil, Écully, Lyon, Marseille, Nantes, Nice, Paris
Életkor
50 év and over
People
561 worldwide
Run by
AbbVie
See details and how to joinNCT07007065 · EU 2024-512298-28-00
3. fázisTaking people
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Where
Bordeaux, Lyon Cedex 04, Marseille, Paris, Paris Cedex 10
Életkor
50 év and over
People
1000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT03683251 · EU 2023-507131-38-00
3. fázisTaking people
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Where
Marseille, Nantes, Nice
Életkor
50 év and over
People
480 worldwide
Run by
4D Molecular Therapeutics
See details and how to joinNCT07064759
2. fázisCsak meghívásos
ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study
Where
Dijon, Nantes
Életkor
55 év and over
People
225 worldwide
Run by
Gyroscope Therapeutics Limited
See details and how to joinNCT05481827 · EU 2024-510946-15-00
2/3. fázisTaking people
A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003)
Where
Créteil, Dijon, Écully, Lyon Cedex 04, Marseille, Paris, Saint-Cyr-Sur-Loire
Életkor
18 év and over
People
250 worldwide
Run by
Eyebiotech Limited
See details and how to join2025-524894-17-00 · EU 2025-524894-17-00
No phaseTaking people
Survival of Monocytes Collected From Patients With Atrophic AMD in Retinal Pigmented Epithelium Explants
Where
Lyon
Életkor
15 év and over
People
80
Run by
Hospices Civils de Lyon
See details and how to joinNCT04697095
No phaseTaking people
Functional and Anatomical Visual Investigations in Patients With Early Forms of Age-related Macular Degeneration
Where
Paris
Életkor
18 év and over
People
120
Run by
Fondation Ophtalmologique Adolphe de Rothschild
See details and how to joinNCT06694272
2. fázisTaking people
Evaluating Aganirsen Eye Drops to Reduce the Number of Aflibercept Injections in Wet Age-Related Macular Degeneration Patients.
Where
Amiens Cedex 1, Bobigny Cedex, Bordeaux, Créteil, Lyon, Lyon Cedex 04, Marseille, Montauban, Nantes, Nice, Saint-Cyr-Sur-Loire, Saint-Priest-en-Jarez, Strasbourg, Toulouse Cedex 9, Tours
Életkor
18 év and over
People
162
Run by
Laboratoires Kol
See details and how to join2026-526775-27-00 · EU 2026-526775-27-00
2/3. fázisTaking people
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Where
Créteil, Marseille, Saint-Cyr-sur-Loire
Életkor
50 év and over
People
960 worldwide
Run by
EyeBiotech Ltd.
See details and how to joinNCT07496567
2. fázisNot yet taking people in Franciaország
An Open-label Safety, Tolerability and Exploratory Efficacy Clinical Trial of PST-611 in Geographic Atrophy
Where
La Tronche, Paris
Életkor
65 év and over
People
24
Run by
Eyevensys
See details and how to joinNCT07705568 · EU 2025-525008-12-00
No phaseTaking people
Biomarkers and Choroidal Neovascularization
Where
Paris, Suresnes
Életkor
18 év to 90 év
People
250
Run by
Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT04439708
No phaseTaking people
Acute Intra Ocular Pressure Monitoring After Aflibercept 8mg/0.07mL
Where
Toulon
Életkor
18 év and over
People
100
Run by
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
See details and how to joinNCT06893965
No phaseTaking people
Study of Switching to Aflibercept 8 mg in Patients With Refractory or Dependent Exudative Age-related Macular Degeneration
Where
Nantes
Életkor
18 év and over
People
100
Run by
Nantes University Hospital
See details and how to joinNCT07423429
No phaseTaking people
Multicenter Real-life Observational Study Switched Aflibercept or Ranibizumab to Faricimab in Patients With AMD.
Where
Nantes
Életkor
18 év and over
People
100
Run by
Nantes University Hospital
See details and how to joinNCT06271330
No phaseTaking people
Ethical Issues of Using Gene Therapy in the Treatment of AMD
Where
Nantes
Életkor
18 év and over
People
30
Run by
Nantes University Hospital
See details and how to joinNCT07004361
No phaseTaking people
Medico-economic Evaluation of Anti-VEGF Treatments in the Treatment of naïve Age-related Macular Degeneration (AMD): a Model Adapted to the French Context
Where
Amiens
Életkor
18 év to 70 év
People
600
Run by
Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT03577041
No phaseTaking people
International Study of the SING IMT™ Prosthesis in Pseudophakic patiEnts With Stable Moderate to Profound Bilateral Central vIsion Impairment Due to adVancEd AMD / PERSPECTIVE Study
Where
Marseille, Saint-Jean-de-Luz, Strasbourg
Életkor
55 év and over
People
44 worldwide
Run by
VisionCare, Inc.
See details and how to joinNCT07164378
2. fázisTaking people
Long-Term Analysis of DImethyl Fumarate, to Slow the Growth of Areas of Geographic Atrophy
Where
Créteil, Dijon, Lyon Cedex 04, Marseille, Nantes, Paris, Paris Cedex 10, Poitiers, Rouen, Saint-Cyr-Sur-Loire
Életkor
55 év to 85 év
People
90
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT04292080 · EU 2024-510741-33-00
No phaseTaking people
High Resolution, High-speed Multimodal Ophthalmic Imaging
Where
Paris
Életkor
18 év and over
People
1200
Run by
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
See details and how to joinNCT04129021
No phaseNot yet taking people in Franciaország
Comparison of the Sensibility of Swept Source Optical Coherence Tomography Devices in the Detection of Neovascularisation in Large Pigment Epithelium Detachments
Where
Créteil
People
50
Run by
University of Trieste
See details and how to joinNCT07143526
No phaseTaking people
Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression
Where
Dijon
Életkor
55 év to 99 év
People
200 worldwide
Run by
Medical University of Vienna
See details and how to joinNCT06351657